SCHEMBL13774604

SCHEMBL13774604

CN(C(=O)NCCOc1ccccc1)c1ccc(S)cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48
RAB9A P51151 8/20 0.44
NPC1 O15118 7/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HPGD P15428 1/20 0.44
RECQL P46063 2/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
MAPT P10636 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 1/20 0.42
NTSR1 P30989 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NOD2 Q9HC29 1/20 0.42
ALDH1A1 P00352 1/20 0.42
BRD4 O60885 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13774600 0.84 HPGD (0.37) RAB9ANPC1SMN1; SMN2L3MBTL1HPGD
SCHEMBL4148343 0.82 MTNR1A (0.43) MTNR1AMTNR1BRAB9ANPC1SMN1; SMN2
SCHEMBL13774594 0.78 HTR2A (0.35) HTTALDH1A1
SCHEMBL13774602 0.77 NPC1 (0.35) RAB9ANPC1SMN1; SMN2L3MBTL1HPGD
SCHEMBL13774590 0.75 SMN1; SMN2 (0.47) RAB9ANPC1SMN1; SMN2L3MBTL1HPGD
SCHEMBL13774601 0.74 SMN1; SMN2 (0.34) SMN1; SMN2L3MBTL1HPGDKMT2AMEN1
SCHEMBL13774597 0.73 HPGD (0.36) RAB9ANPC1SMN1; SMN2L3MBTL1HPGD
SCHEMBL13774588 0.72 PTGIR (0.39)
SCHEMBL13774613 0.70 NPC1 (0.41) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL6137763 0.69 ALOX5 (0.48) RAB9ANPC1SMN1; SMN2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 MTNR1A 3541/4885MTNR1B 3670/4885RAB9A 642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.